Company Profile
Fusion Antibodies Plc
ni039740•Public Limited With Share Capital
Get Full Access
29/11/2000
25 years
8
24
72110
moderate risk
Company Overview
Registration, classification & business activity
Fusion Antibodies Plc (ni039740) is a public limited with share capital incorporated on 29/11/2000 (25 years old) and registered in belfast, BT170QL. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Since 2001, fusion antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry. we offer a complete range of antibody-related services in discovery, engineering and supply and have guided hundreds of projects thr...
Financial Overview
£1.41M
£742.0K
£669.0K
£1.97M
£359.0K
Key Metrics
24
Employees
8
Directors
106
Shareholders
18
Patents
Board of Directors
Charges
5
Registered
2
Outstanding
0
Part Satisfied
3
Satisfied
Innovate Grants
This company received a grant of £230265.0 for Nova-Care. The project started on 01/10/2016 and ended on 30/09/2019.
This company received a grant of £545528.0 for Development Of A Unique Humanized Dr5 Activating Antibody For Treating Therapy-Resistant Cancers. The project started on 01/05/2025 and ended on 31/10/2026.
+1 more grants available
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating